Matrix metalloproteinases as therapeutic targets in breast cancer

HIGHLIGHTS

  • who: Mi Jeong Kwon from the Institut du de Montpellier (ICM), France University of Patras, Greece have published the article: Matrix metalloproteinases as therapeutic targets in breast cancer, in the Journal: (JOURNAL)

SUMMARY

    Breast cancer is the most frequent malignancy and the leading cause of cancer-related death in women worldwide. Based on the hormone_receptor (estrogen receptor or progesterone receptor ) and human epidermal growth factor receptor 2 (HER2) status, breast cancer is classified into four main subtypes; hormone_receptor-positive/HER2-negative Frontiers in Oncology frontiersin.org 10.3389/fonc.2022.1108695 substrates. Macrophagederived . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?